Press Releases | Medtronic

Month Year

Email alerts

Sep 16, 2014

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

IN.PACT Global Study Reports Favorable Outcomes in Real-World Patient Population and Validates Key Findings from IN.PACT SFA Trial

WASHINGTON -- Sept. 16, 2014 -- Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference, the latest clinical and economic data on the IN.PACT Admiral...
Sep 15, 2014

Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials

DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 15, 2014-- Covidien plc announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the...
Sep 15, 2014

Medtronic Launches SEEQ(TM) Wearable Cardiac Monitoring System in United States

New External Heart Monitor and Remote Monitoring Center Help Patients Find Answers to Unexplained Cardiac Symptoms

MINNEAPOLIS - September 15, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the SEEQ(TM) Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor...
Sep 13, 2014

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Cost Effectiveness of Self-Expanding Valve Driven by Improved Quality of Life Benefit and Superior One-Year Survival Rates over Surgical Aortic Valve Replacement

WASHINGTON, D.C., and MINNEAPOLIS - Sept. 13, 2014 - In the first-ever in-trial cost effectiveness analysis of transcatheter aortic valve replacement (TAVR) for patients at high risk for surgery,...
Sep 13, 2014

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

TCT Late-Breaking First Report Reveals High Survival, Low Stroke Rates and Sustained Valve Performance

WASHINGTON, D.C. and MINNEAPOLIS - Sept. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today announced new data showing that transcatheter aortic valve replacement (TAVR) with the CoreValve® System...
Sep 11, 2014

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

Superior Deliverabilityi and Uncompromising Performance Distinguishes New Angioplasty Balloon

MINNEAPOLIS -- Sept. 11, 2014 -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora(TM) Noncompliant Balloon...
Sep 11, 2014

Medtronic Named One of the World's Leading Companies for Sustainability

MINNEAPOLIS - Sept. 11, 2014 - Medtronic, Inc. (NYSE: MDT) was recognized as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability World Index...
Sep 10, 2014

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

First Patients Successfully Treated in Study to Evaluate Next Generation Transcatheter Valve

MINNEAPOLIS - Sept. 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the...
Sep 3, 2014

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

Next-Generation TAVI System Offers Ability to Recapture and Reposition During Deployment

MINNEAPOLIS - Sept. 3, 2014 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM) R System for transcatheter aortic valve implantation...
Sep 2, 2014

Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference

MINNEAPOLIS - Sept 2, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global Healthcare Conference,...

Show per page